C3.ai stock downgraded by Oppenheimer after weak preliminary results

Published 13/08/2025, 08:10
C3.ai stock downgraded by Oppenheimer after weak preliminary results

Investing.com - C3.ai (NYSE:AI) was downgraded by Oppenheimer from Outperform to Perform, with the firm removing its previous $45 price target following disappointing preliminary first-quarter results. The stock has fallen sharply, with InvestingPro data showing a 27% decline in the past week alone, while maintaining a high beta of 1.97, indicating significant volatility.

The enterprise AI software provider significantly reduced its revenue expectations for the first quarter of fiscal 2026, lowering guidance from approximately $105 million to around $70 million. This represents a 35% sequential decline, raising concerns about the recurring nature of the company’s subscription revenues.

C3.ai also increased its projected non-GAAP operating loss from $29 million to $58 million, further highlighting the company’s financial challenges. The preliminary results prompted Oppenheimer to dramatically reduce its estimates for the company.

CEO and founder Tom Siebel will be stepping down from his position due to health issues, adding leadership uncertainty during this challenging period for the company.

Oppenheimer expressed concern that these results may indicate secular weakness in underlying trends for C3.ai, noting that the company has become "very difficult to forecast" and suggesting the services may not be working as advertised.

In other recent news, C3.ai reported preliminary first-quarter fiscal 2026 revenue of approximately $70.3 million, marking a 19% decline from the previous year and falling significantly short of the company’s guidance of $104.5 million. This revenue miss has led to a series of analyst actions. Northland downgraded C3.ai’s stock rating from Outperform to Market Perform, citing concerns over missed subscription revenue, which is typically a more predictable stream. UBS lowered its price target for C3.ai from $27 to $23 while maintaining a Neutral rating, highlighting the substantial revenue shortfall.

Similarly, Wedbush reduced its price target from $35 to $23, although it retained an Outperform rating, describing the recent quarter as challenging for the company. Needham continued to hold a Hold rating on the stock, pointing out the 33% miss at the midpoint of the company’s revenue guidance. In a strategic move, C3.ai announced the launch of its Strategic Integrator Program, allowing partners to license its Enterprise AI platform to develop and market their own AI applications. This program aims to provide partners with intellectual property rights, access to C3.ai’s developer community, and collaborative resources.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.